Diagnostische und prognostische Performance des LiverRisk-Scores in der Tertiärversorgung
Lorenz Balcar(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), Lukas Hartl(Medical University of Vienna), Bernhard Scheiner(Medical University of Vienna), J. Maurer(Medical University of Vienna), S Gensluckner(Paracelsus Medical University), Georg Semmler(University of Southern Denmark), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Daniela Neumayer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), K Stopfer(Medical University of Vienna), L. Fritz(Medical University of Vienna), Elmar Aigner, Maria Schwarz(Friedrich Schiller University Jena), Andreas Schedlbauer(Medical University of Vienna)
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k